Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haynes

Showing results (431-440 of 843) with videos related to

Pageof 85
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1989
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopesT J Palker, T J Matthews, A Langlois, et al.
AIDS (London, England)|August 26, 1998
Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research InitiativeJ A Bartlett, S S Wasserman, C B Hicks, et al.
Molecular Therapy. Methods & Clinical Development|May 26, 2022
Erratum: Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1Edmund G Wee, Nathifa A Moyo, Kevin O Saunders, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2009
Role of HIV membrane in neutralization by two broadly neutralizing antibodiesS Munir Alam, Marco Morelli, S Moses Dennison, et al.
Journal of Virology|January 28, 2006
Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 EnvMark J Cayabyab, Avi-Hai Hovav, Tsungda Hsu, et al.
Journal of Virology|November 16, 2004
Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boostingJames W Peacock, Sushila K Nordone, Shawn S Jackson, et al.
Molecular Therapy. Methods & Clinical Development|August 2, 2019
Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1Edmund G Wee, Nathifa A Moyo, Kevin O Saunders, et al.
The American Journal of Medicine|July 1, 1988
Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North CarolinaJ B Weinberg, R A Spiegel, D L Blazey, et al.
Journal of Virology|March 20, 2009
Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responsesMark J Cayabyab, Birgit Korioth-Schmitz, Yue Sun, et al.
The Journal of Infectious Diseases|September 25, 2008
Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responsesLiyou Qiu, Dan Huang, Cystal Y Chen, et al.
Pageof 85

Showing results (431-440 of 843) with videos related to

Sort By:
Pageof 85
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1989
Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopesT J Palker, T J Matthews, A Langlois, et al.
AIDS (London, England)|August 26, 1998
Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research InitiativeJ A Bartlett, S S Wasserman, C B Hicks, et al.
Molecular Therapy. Methods & Clinical Development|May 26, 2022
Erratum: Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1Edmund G Wee, Nathifa A Moyo, Kevin O Saunders, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2009
Role of HIV membrane in neutralization by two broadly neutralizing antibodiesS Munir Alam, Marco Morelli, S Moses Dennison, et al.
Journal of Virology|January 28, 2006
Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 EnvMark J Cayabyab, Avi-Hai Hovav, Tsungda Hsu, et al.
Journal of Virology|November 16, 2004
Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boostingJames W Peacock, Sushila K Nordone, Shawn S Jackson, et al.
Molecular Therapy. Methods & Clinical Development|August 2, 2019
Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1Edmund G Wee, Nathifa A Moyo, Kevin O Saunders, et al.
The American Journal of Medicine|July 1, 1988
Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North CarolinaJ B Weinberg, R A Spiegel, D L Blazey, et al.
Journal of Virology|March 20, 2009
Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responsesMark J Cayabyab, Birgit Korioth-Schmitz, Yue Sun, et al.
The Journal of Infectious Diseases|September 25, 2008
Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responsesLiyou Qiu, Dan Huang, Cystal Y Chen, et al.
Pageof 85